The Company reiterated its revenue guidance of $14.0-$15.0 million for the year ending December 31, 2023. The Company intends to provide a detailed operational and financial update during its second quarter 2023 earnings call in August 2023.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ECOR:
- electroCore’s vagus nerve stimulation selected for NFL-funded concussion study
- electroCore announces its TAC-STIM nVNS was selected to be part of AFRL A2PEX
- TAC-STIM™ Non-Invasive Vagal Nerve Stimulation Selected for Inclusion in the Air Force Research Laboratories Real-Time Assessing and Augmenting Cognitive Performance in Extreme Environments Project
- electroCore to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC
- electroCore to present poster on nVNS at American Headache Society meeting
